Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis

…, H Moschouris, E Bouma, J Koskinas… - Cardiovascular and …, 2012 - Springer
Purpose The purpose of this study was to report on the 5-year survival of hepatocellular
carcinoma (HCC) patients treated with DC Bead loaded with doxorubicin (DEB-DOX) in a …

[PDF][PDF] Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients

A Laras, J Koskinas, E Dimou, A Kostamena… - …, 2006 - Wiley Online Library
Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is responsible for viral
persistence in the natural course of chronic HBV infection and during prolonged antiviral therapy …

Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil …

N Sheron, G Bird, J Koskinas, B Portmann, M Ceska… - Hepatology, 1993 - journals.lww.com
Acute alcoholic hepatitis is characterized by a unique degree of liver neutrophil infiltration,
often accompanied by marked peripheral neutrophilia in the absence of demonstrable …

Pylephlebitis: an overview of non-cirrhotic cases and factors related to outcome

…, G Theodossiades, J Koskinas… - … journal of infectious …, 2010 - Taylor & Francis
Pylephlebitis is a condition with significant morbidity and mortality. We review herein 100
relevant case reports published since 1971. Eighty-one patients were reported with acute …

Safety Profile of Sequential Transcatheter Chemoembolization with DC Bead: Results of 237 Hepatocellular Carcinoma (HCC) Patients

…, S Dourakis, E Alexopoulou, J Koskinas… - Cardiovascular and …, 2011 - Springer
Introduction Complications of chemoembolization performed with DC Bead ™ loaded with
doxorubicin (DEBDOX) of diameters 100–300 μm and 300–500 μm are presented in this …

[HTML][HTML] Chemoembolization of hepatocellular carcinoma with HepaSphere 30–60 μm. Safety and efficacy study

…, E Karagiannis, A Marinis, J Koskinas… - Cardiovascular and …, 2014 - Springer
Background This study examined the safety, pharmacokinetics, and efficacy of transarterial
chemoembolization of hepatocellular carcinoma (HCC) using a newly developed size of a …

Selective hepatic vascular exclusion versus Pringle maneuver in major liver resections: prospective study

…, CI Farantos, DC Voros, DC Kannas, JS Koskinas - World journal of …, 2003 - Springer
Selective hepatic vascular exclusion (SHVE) and the Pringle maneuver are two methods used
to control bleeding during hepatectomy. They are compared in a prospective randomized …

[HTML][HTML] Liver histology in ICU patients dying from sepsis: a clinico-pathological study

J Koskinas, IP Gomatos, DG Tiniakos… - World journal of …, 2008 - ncbi.nlm.nih.gov
AIM: To determine end-stage pathologic changes in the liver of septic patients dying in the
intensive care unit. METHODS: Needle liver biopsies obtained immediately after death from …

Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study

…, K Baou, G Papatheodoridis, J Koskinas… - American journal of …, 2010 - academic.oup.com
Background Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease
both in the general and pediatric population and has been associated with increased …

Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead

…, E Alexopoulou, K Chatzimichail, B Hall, J Koskinas… - Abdominal …, 2008 - Springer
Purpose To examine the results of segmental transcatheter arterial chemoembolization with
doxorubicin-loaded DC Bead in the treatment of hepatocellular carcinoma (HCC) in non-…